痰热清注射液治疗卒中相关性肺炎的效果及对细菌清除的影响

Abstract
Figure/Table
References (26)
Related Citation (15)

Download: PDF (567 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of Tanreqing Injection on the treatment of stroke-associated pneumonia (SAP) and its effect on bacterial clearance. Methods A total of 84 SAP patients admitted to Nanjing Tongren Hospital, Southeast University School of Medicine from July 2018 to April 2021 were selected as the research subjects. They were divided into the observation group and the control group according to the random number table method, with 42 cases in each group. The control group was treated with Cefoperazone / Sulbactam, the observation group was treated with Tanreqing Injection on the basis of the control group. Traditional Chinese medicine syndrome score, clinical efficacy, bacterial clearance, serum inflammatory factor level (tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6] and C-reaction protein [CRP]) and the occurrence of adverse drug reactions were evaluated after one week of treatment. Results After one week of treatment, traditional Chinese medicine syndrome scores of the two groups were lower than those before treatment, and the observation group was lower than the control group, and the differences were statistically significant (P < 0.05). The clinical efficacy of the observation group was better than that of the control group, and the difference was statistically significant (P < 0.05). The total clearance rate of pathogens in the observation group was higher than that of the control group, and the difference was statistically significant (P < 0.05). After one week of treatment, the levels of TNF-α, IL-6, and CRP in the two groups were lower than those before treatment, and the observation group was lower than the control group, and the differences were statistically significant (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion The treatment of Tanreqing Injection combined with Cefoperazone / Sulbactam for SAP patients can effectively improve the clinical treatment effect of patients, reduce traditional Chinese medicine syndrome scores, increase pathogen clearance, reduce inflammation, and have good safety.

Key words： Tanreqing Injection Cefoperazone / Sulbactam Stroke-associated pneumonia Bacterial clearance Clinical efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Jingtao SHANG Bing▲

Cite this article:

WANG Jingtao SHANG Bing▲. Effect of Tanreqing Injection on the treatment of stroke-associated pneumonia and its effect on bacterial clearance[J]. 中国医药导报, 2022, 19(21): 119-122.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I21/119

[1] 张立，周继红，谢嘉嘉，等.清热化痰通腑方治疗痰热蕴肺型卒中相关性肺炎41例[J].环球中医药，2021，14（9）：1713-1716.
[2] 张溪，张伟，孙燕，等.岭南甄氏益气清热通腑法联合针刺治疗卒中相关性肺炎的临床疗效[J].实用医学杂志，2019，35（5）：818-821.
[3] 斯琴高娃，徐静，哈斯棍，等.纤维支气管镜肺泡灌洗在机械通气下卒中相关性肺炎治疗中的应用效果研究[J].安徽医药，2021，25（1）：47-50.
[4] 杨涛，欧阳斐，赵焱，等.呼吸康复训练治疗出血性脑卒中相关性肺炎的疗效观察[J].中华物理医学与康复杂志，2019，41（3）：210-212.
[5] 李丽绚，王洁，刘义锋，等.急性缺血性脑卒中介入术后肺部感染病原菌耐药性及其影响因素[J].中华医院感染学杂志，2021，31（3）：395-398.
[6] 潘政，程小丽，马永贞，等.痰热清注射液治疗急性脑卒中伴发卒中相关性肺炎的临床观察[J].中国中医急症，2020，29（5）：873-875.
[7] 吴晓升，张建源，王蔚.雾化吸入痰热清注射液对卒中相关性肺炎发生及细菌清除效果的影响[J].新中医，2019， 51（1）：96-99.
[8] 中华医学会神经病学分会，中华医学会神经病学分会神经康复学组，中华医学会神经病学分会脑血管病学组.中国脑卒中早期康复治疗指南[J].中华神经科杂志，2017， 50（6）：405-412.
[9] 中国卒中学会急救医学分会，中华医学会急诊医学分会卒中学组，中国老年医学学会急诊医学分会急救与创伤研究教育部重点实验室.卒中相关性肺炎诊治中国专家共识[J].中华急诊医学杂志，2010，49（12）：1075-1078.
[10] 张伯礼，吴勉华.中医内科学[M].7版.北京：中国中医药出版社，2017.
[11] 郑筱萸.中药新药临床研究指导原则（试行）[M].北京：中国医药科技出版社，2002：367-369.
[12] 抗菌药物临床应用指导原则（2015版）[C].//2015年全国临床药师高峰论坛暨江西省医院药事管理学术年会论文集，2015：1-7.
[13] 颜博，岳宗伟，李华坚，等.卒中相关性肺炎患者感染病原菌种类及其与血清cf-DNA/NETs的相关性[J].中国病原生物学杂志，2021，16（8）：937-939，946.
[14] 张辉，陈敏，刘绪宏.重症与非重症急性期脑卒中相关性肺炎病原学临床研究[J].武警医学，2020，31（11）：935-939，943.
[15] 韩旭翠，江舟，周凌云.金远林辨治卒中相关性肺炎多重耐药验案举隅[J].中医药导报，2020，26（1）：130-132.
[16] 吴倩，路伟.老年急性脑出血并发相关性肺炎的危险因素分析及风险预测模型的建立[J].贵州医科大学学报，2020，45（10）：1219-1224.
[17] 颜凡棋，覃燕琼，姚春栉，等.中药汤剂联合西药治疗卒中相关性肺炎疗效和安全性的Meta分析[J].现代中药研究与实践，2019，33（6）：54-59.
[18] 刘增强，岳新鹏，王少华，等.脾多肽辅助治疗对急性卒中相关性肺炎的影响[J].重庆医学，2019，48（18）：3130-3133.
[19] 邓松松，任长娟.痰热清注射液对重症肺炎患者的耐药菌感染率改善作用[J].药物评价研究，2021，44（2）：381-384.
[20] 胡妮娜，戴文涛，刘娴.痰热清注射液联合哌拉西林钠他唑巴坦钠辅助心理干预治疗急性肺炎临床研究[J].新中医，2020，52（5）：65-67.
[21] 孙建光，李春，郑彩莲，等.痰热清注射液联合西医疗法治疗重症肺炎临床观察[J].北京中医药，2020，39（1）：66-69.
[22] 杨原，孙志宏，闫竹琴.头孢哌酮/舒巴坦联合痰热清注射液对老年患者院内铜绿假单胞菌肺炎的疗效[J].中华老年多器官疾病杂志，2021，20（9）：683-688.
[23] 问莉娜，郭珍，赵欢，等.清金化痰汤对卒中相关性肺炎患者的影响[J].西部中医药，2020，33（4）：93-95.
[24] 李德需，张丽妍，赵永辰，等.白虎汤加减联合针灸治疗痰热腑实型卒中相关性肺炎的临床疗效以及对血清炎症因子的影响[J].辽宁中医杂志，2019，46（4）：749-752.
[25] 黄兰，王宋平.卒中相关性肺炎病原学特点及预后影响因素分析[J].中国抗生素杂志，2020，45（10）：1092-1096.
[26] 关锦贞，张勇，陈瑶.清金化痰汤治疗脑卒中相关肺炎痰热壅肺证的临床效果[J].中国当代医药，2020，27（6）：163-166.